咨询与建议

限定检索结果

文献类型

  • 2 篇 期刊文献

馆藏范围

  • 2 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 2 篇 医学
    • 2 篇 临床医学

主题

  • 2 篇 novel hormonal t...
  • 1 篇 bone flare
  • 1 篇 case report
  • 1 篇 safety managemen...
  • 1 篇 apalutamide
  • 1 篇 adverse event
  • 1 篇 metastatic hormo...
  • 1 篇 prostate cancer

机构

  • 1 篇 national cancer ...
  • 1 篇 peking union med...
  • 1 篇 university of ma...
  • 1 篇 sun yat‐sen memo...
  • 1 篇 the first people...
  • 1 篇 henan provincial...
  • 1 篇 seoul national u...
  • 1 篇 xijing hospital ...
  • 1 篇 west china hospi...
  • 1 篇 qilu hospital of...
  • 1 篇 department of ur...
  • 1 篇 peking universit...
  • 1 篇 the second hospi...
  • 1 篇 the first affili...
  • 1 篇 xiangya hospital...
  • 1 篇 fourth affiliate...
  • 1 篇 beijing cancer h...
  • 1 篇 zhongnan hospita...
  • 1 篇 kindai universit...
  • 1 篇 shanxi provincia...

作者

  • 1 篇 shudong cheng
  • 1 篇 qing zou
  • 1 篇 renu eapen
  • 1 篇 jinkai shao
  • 1 篇 wanhai xu
  • 1 篇 chi‐fai ng
  • 1 篇 xue-ping zhang
  • 1 篇 dong-yu yang
  • 1 篇 yuan-cheng du
  • 1 篇 jianming guo
  • 1 篇 ke-hao li
  • 1 篇 baiye jin
  • 1 篇 nianzeng xing
  • 1 篇 hiroji uemura
  • 1 篇 tianxin lin
  • 1 篇 xinghuan wang
  • 1 篇 weijun qin
  • 1 篇 yong-xiang li
  • 1 篇 zhisong he
  • 1 篇 edmund chiong

语言

  • 2 篇 英文
检索条件"主题词=novel hormonal therapy"
2 条 记 录,以下是1-10 订阅
排序:
Bone flare after initiation of novel hormonal therapy in patients with metastatic hormone-sensitive prostate cancer:A case report
收藏 引用
World Journal of Clinical Cases 2022年 第15期10卷 4985-4990页
作者: Ke-Hao Li Yuan-Cheng Du Dong-Yu Yang Xin-Yuan Yu Xue-Ping Zhang Yong-Xiang Li Liang Qiao Department of Clinic Weifang Medical UniversityWeifang 261000Shandong ProvinceChina Department of Urology Weifang People's HospitalWeifang 261000Shandong ProvinceChina
BACKGROUND The 2020 European Association of Urology prostate cancer guidelines recommend androgen deprivation therapy(ADT)in combination with apalutamide and enzalutamide,a new generation of androgen receptor antagoni... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论
Consensus on safety management of novel hormonal therapy for advanced prostate cancer
收藏 引用
UroPrecision 2023年 第2期1卷 53-71,I0005页
作者: Sujun Han Shudong Cheng Degang Ding Jianming Guo Zhisong He Baiye Jin Zhigang Ji Tianxin Lin Yuanjie Niu Weijun Qin Benkang Shi Jinkai Shao Xi'nan Sheng Qiang Wei Xin Wang Xinghuan Wang Shujie Xia Wanhai Xu Qing Zou Xiongbing Zu Renu Eapen Chi‐Fai Ng Hirotsugu Uemura Hiroji Uemura Cheol Kwak Jae Young Joung Marniza Saad Edmund Chiong Nianzeng Xing National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina The First People's Hospital of Jinzhong JinzhongChina Henan Provincial People's Hospital ZhengzhouChina Zhongshan Hospital Fudan UniversityShanghaiChina Peking University First Hospital BeijingChina The First Affiliated Hospital Zhejiang University School of MedicineHangzhouChina Peking Union Medical College Hospital BeijingChina Sun Yat‐sen Memorial Hospital Sun Yat‐sen UniversityGuangzhouChina The Second Hospital of Tianjin Medical University TianjinChina Xijing Hospital of Air Force Military Medical University Xi'anChina Qilu Hospital of Shandong University JinanChina Shanxi Provincial People's Hospital TaiyuanChina Beijing Cancer Hospital BeijingChina West China Hospital Sichuan UniversityChengduChina Zhongnan Hospital of Wuhan University WuhanChina Shanghai General Hospital ShanghaiChina Fourth Affiliated Hospital of Harbin Medical University HarbinChina Jiangsu Cancer Hospital NanjingChina Xiangya Hospital of Central South University ChangshaChina Peter MacCallum Cancer Centre VictoriaAustralia The Chinese University of Hong Kong Hong KongChina Kindai University Faculty of Medicine Graduate School of Medical Sciences OsakaJapan Yokohama City University Medical Center KanagawaJapan Seoul National University Hospital SeoulKorea National Cancer Center Gyeonggi‐doKorea University of Malaya Medical Centre Wilayah PersekutuanMalaysia National University Hospital SingaporeSingapore
Prostate cancer(PCa)is one of the most prevalent malignant tumors in men,accompanied by high incidence and mortality *** hormonal therapy(NHT)has emerged as the primary treatment for advanced PCa,providing noticeable ... 详细信息
来源: 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论